Gonadal damage and effects on fertility in adult patients with haematological malignancy undergoing stem cell transplantation

Bone Marrow Transplantation

Volumn 17, Issue 1, 1996, Pages 5-11

  Chatterjee, R ^a,b   Goldstone, A H ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Cytotoxic drugs; Fertility; Gonadal damage; Haematological malignancy; Total body irradiation

Indexed keywords

BLEOMYCIN; BUSULFAN; CARMUSTINE; CHLORMETHINE DERIVATIVE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ESTROGEN; ETOPOSIDE; GONADORELIN AGONIST; IMIDAZOLECARBOXAMIDE; MELPHALAN; METHOTREXATE; PREDNISONE; PROCARBAZINE; PROGESTERONE; VINCRISTINE;

ALLOGENIC BONE MARROW TRANSPLANTATION; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CRYOPRESERVATION; ENDOCRINE FUNCTION; FERTILITY; FOLLOW UP; GONAD DYSFUNCTION; HEMATOLOGIC DISEASE; HODGKIN DISEASE; HUMAN; MEDICAL ETHICS; OOCYTE; OVARY INSUFFICIENCY; PATHOPHYSIOLOGY; PATIENT CARE; PATIENT SELECTION; PREGNANCY; PRIORITY JOURNAL; RELIGION; REVIEW; SPERM PRESERVATION; STEM CELL TRANSPLANTATION; TESTIS DISEASE; WHOLE BODY RADIATION;

ADULT; ESTROGEN REPLACEMENT THERAPY; FEMALE; FERTILITY; GONADS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA; LYMPHOMA; OVARIAN FAILURE, PREMATURE; SEMEN PRESERVATION;

EID: 0030032968     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. Koyama H, Wada T, Nishizawa Y. Cyclophosphamide induced ovarian failure and its therapeutic significance in patients with breast cancer. Cancer 1977; 39: 1403-1409.
2. Martin RH. Sperm chromosomal analysis after radiotherapy. Hum Genet 1988; 79: 392-398.
3. Shamberger RC, Rosenberg SA, Seipp CA et al. Effects of high dose methotrexate and vincristine on ovarian and testicular functions in patients undergoing post-operative adjuvant treatment for osteosarcoma. Cancer Treat Rep 1981; 65: 739-746.
4. Whitehead E, Shalet SM, Blackledge G et al. The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease. Cancer 1983; 52: 982-993.
5. Soborinho LJ, Levme RA. De Conti RC et al. Amenorrhoea in patients with Hodgkin's disease treated with anti-neoplastic agents. Am J Obstet Gynaecol 1971; 109: 135-139.
6. Klein C, Glode M. Gonadal complications. In: Armitage J, Antman K (eds). High Dose Cancer Therapy. Williams and Wilkins: Baltimore, 1992, pp 555-566.
7. Sanders JE, Buckner DC, Amos D et al. Ovarian function following bone marrow transplantation for aplastic anemia or leukemia. J Clin Oncol 1988; 6: 813-818.
8. Sklar CA, Kim TH, Williamson JF et al. Ovarian function after successful bone marrow transplantation in post monarchal females. Med Paed Oncol 1983; 11: 361-364.
9. Warne GL, Fairley KF, Hobbs JB et al. Cyclophosphamide-induced ovarian failure. New Engl J Med 1973; 289: 1159-1162.
10. Sanders JE. Growth and development after bone marrow transplantation. In: Forman SJ, Blume KJ. Thomas ED (eds). Bone Marrow Transplantation. Blackwell Scientific Publications: Boston, 1993, pp 527-537.
11. Grunnet D, Nyfors A, Hansen K. Studies on human semen in topical corticosteroid treated and in methotrexate treated psoriatics. Dermatologica 1977; 154: 78-84.
12. Guesry P, Lenoir G, Broyer M. Gonadal effects of chlorambucil given to prepubertal and pubertal boys for nephrotic syndrome. J Paed 1992; 92: 299-303.
13. Richter P, Calamera JC, Morgenseld MC et al. Effects of chlorambucil on spermatogenesis in the human with malignant lymphoma. Cancer 1970; 25: 1026-1030.
14. Shamberger RC, Sherins RJ, Ziegler JL et al. Effects of post-operative adjuvant radiotherapy and chemotherapy on ovarian function in women undergoing treatment for soft tissue sarcoma. J Natl Cancer Inst 1981; 67: 1213-1218.
15. Spitz S. The histological effects of nitrogen mustards on human tumors and tissues. Cancer 1948; 1: 383-398.
16. Weinblatt ME. Toxicity of low dose methotrexate in rheumatoid arthritis. J Rheumat 1985; 12 (suppl. 12): 35-39.
17. Chatterjee R, Mills W, Katz M et al Evidence of transient hypothalamic insufficiency following fractionated TBI in patients with hematological malignancy. Blood 1992; 80: (suppl. 1): 139 (abstr.).
18. Mills W, Chatterjee R, McGarrigle HHG et al. Partial hypopituitarism following TBI in adult patients with haematological malignancy. Bone Marrow Transplant 1994; 14: 471-473.
19. Littley MD, Shalet SM, Morgenstern GR et al. Endocrine and reproductive dysfunction following fractionated total body irradiation in adults. Q J Med 1991; 78: 265-274.
20. Wallace WHB, Shalet SM, Crowne EC et al. Ovarian failure following abdominal irradiation in childhood: natural history and prognosis. Clin Oncol 1989; 1: 75-79.
21. Chatterjee R. Mills W, Patel A et al. Biophysical and biochemical assessment of endometrium in patients treated by ablative chemotherapy vs TBI used as preconditioning regimen for BMT. Br J Haematol 1994; 86 (suppl. 1): 82.
22. Coleman N, Langler M. Late complications of cancer therapy. In: Moossa AR, Schimpff SC, Robson MC (eds). Comprehensive Textbook of Oncology, (vol 2; second edn) Williams and Wilkins: Baltimore, 1992, pp 1802-1807.
23. Perry MC. Complications of chemotherapy. In: Moossa AR, Schimpff SC, Robson MC (eds). Comprehensive Textbook of Oncologv (vol 2, second edn) Williams and Wilkins: Baltimore, 1992, pp 1706-1719.
24. Chatterjee R, Mills W, Katz M et al. Germ cell failure and Leydig cell insufficiency in post-pubertal males after autologous bone marrow transplantation with BEAM for lymphoma Bone Marrow Transplant 1994; 13: 519-522.
25. Chatterjee R, Mills W, Katz M et al. A prospective study of pituitary-gonadal function to evaluate short-term effects of ablative regimen in female post-menarchal patients with haematological malignancy (abstract). Blood 1992; 80 (suppl 1): 138.
26. Chatterjee R, Mills W, Katz M et al. A prospective study of pituitary-gonadal function to evaluate short-term effects of ablative chemotherapy or TBI with ABMT in female post-menarcheal patients with haematological malignancy. Bone Marrow Transplant 1994; 13: 531-537.
27. Spinelli S, Chiodi S, Bacigalupo A et al. Ovarian recovery after total body irradiation and allogeneic transplantation: long-term follow-up of 79 females. Bone Marrow Transplant 1994; 14: 373-380.
28. Sanders JE. The impact of marrow transplant preparative regimens on subsequent growth and development. Semin Haematol 1991; 28: 244-249.
29. Shiobara S, Nakao S, Yamaguchi M et al. Complete recovery of sperm production following bone marrow transplantation for leukemia. Bone Marrow Transplant 1992; 10: 313-314.
30. Tutschka PJ, Edward A, Copelan Klein JP. Bone marrow transplantation for leukemia following busulfan and cyclophosphamide regimen. Blood 1987; 70: 1382-1388.
31. Sanger WG, Olson JH, Sherman JK. Semen cryobanking for men with cancer: criteria change. Fertil Steril 1992; 58: 1024-1027.
32. Hendry WF, Stedronska J, Jones CR et al. Semen analysis in testicular cancer and Hodgkin's disease: pre- and post-treatment findings and implications for cryopreservation. Br J Urol 1983; 55: 769-773.
33. Read E, Sanger WG, Armitage JO. Results of semen cryopreservation in young men with testicular carcinoma and lymphoma. J Clin Oncol 1986; 4: 537-539.
34. Scammell GE, White N, Stedronska J et al. Cryopreservation of semen in men with testicular tumour or Hodgkin's disease: results of artificial insemination of their partners. Lancet 1985; 2: 31-32.
35. Berthelsen JG, Shakkebaek NE. Gonadal function in men with testis cancer. Fertil Steril 1983; 39: 68-75.
36. Bracken RB, Smith KD. Is semen cryopreservation helpful in testicular cancer? Urology 1980; 16: 581-583.
37. Rowland GF, Cohen J, Steptoe PC et al. Pregnancy following in vitro fertilization using cryopreserved semen from a man with testicular teratoma. Urology 1985; 26: 33-36.
38. Fishel S, Dowell K, Timson J et al. Micro-assisted fertilization with human gametes. Hum Reprod 1993; 8: 1780-1785.
39. Palmero G, Camus M, Joris H et al. Sperm characteristics and outcome of human assisted fertilization: subzonal insemination and intracytoplasmic injection. Fertil Steril 1993; 59: 826-835.
40. Sterzik K, Rosenbusch B, Noss U. First pregnancies after intravaginal transport and partial zona dissection of human oocytes. Fenil Steril 1993; 60: 582-584.
41. Tournaye H. Semen cryobanking for men with cancer. Fertil Steril 1993; 60: 197.
42. Brandriff BF, Gordon LA, Sharlip I et al. Sperm chromosomal analysis in a survivor of seminoma and associated radiotherapy. Environ Mutagen 1987; 9 (suppl. 8): 44-48.
43. Genesca A, Caballin MR, Miro R et al. Human sperm chromosomes: long-term effect of cancer treatment. Cancer Genet Cytogenet 1990; 46: 251-260.
44. Mastroyannis C. Gamete intrafallopian transfer: ethical considerations, historical development of the procedure, and comparison with other advanced reproductive technologies, Fertil Steril 1993; 60: 389-402.
45. Morris R, Sauer M. New advances in the treatment of fertility in women with ovarian failure. Curr Opin Obstet Cynecol 1993; 5: 368-377.
46. Formogli L, Roccio C, Belorn G et al. Non-surgical flushing of the uterus for pre-embryo recovery: possible clinical applications. Hum Reprod 1990; 5: 329-335.
47. Sauer MV, Bustill M, Gorrill MJ et al. An instrument for the recovery of preimplantation uterine ova. Obstet Gvnecol 1988; 71: 804-806.
48. Rio B, Letur-Konirsch H, Ajechenbaum-Cymbalista F et al. Full-term pregnancy with embryos from donated oocytes in a 36-year-old woman allografted for chronic myeloid leukaemia. Bone Marrow Transplant 1994; 13: 487-488.
49. Atkinson HG, Apperley JF, Dawson K et al. Successful pregnancy after allogeneic bone marrow transplantation for chronic mveloid leukaemia Lancet 1994; 344: 1994 (letter).
50. Critchley HOD, Wallace WHB, Shalet SM et al. Abdominal irradiation in childhood: the potential for pregnancy. Br J Obstet Gynaecol 1992; 99: 392-394.
51. Heimpel H, Arnold R, Hetzel WD et al. Gonadal function after bone marrow transplantation in adult male and female patients. Bone Marrow Transplant 1991; 8 (suppl 1): 21-24.
52. Santoro A, Bonadonna G, Zucali R et al. Therapeutic and toxicological effects of MOPP vs ABVD when combined with RT in Hodgkin's disease. Proc Am Soc Clin Oncol 1981; 22: 522 (abstr. C743).
53. Viviani S, Santoro A, Ragni G et al. Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD. Br J Cancer Clin Oncol 1985; 21: 601-603.
54. Chatterjee R, Mills W, Katz M et al. Evaluation of short and long term effects of TBI is BEAM on H-P-G axis in patients with haematological malignancies. Br J Haematol 1993: 84 (suppl 1): 52 (abstr.).
55. Glode LM, Robinson J, Gould SF. Protection from cyclophosphamide induced testicular damage with an analogue of gonadotrophin releasing hormone. Lancet 1981; i: 1132-1134.
56. Waxman JM, Lister TA, Rees LH et al. Hormonal changes produced by a GnRH analogue in patients with Hodgkin's disease and prostatic cancer. Proc Am Assoc Cancer Res 1983; 24: 182 (abstr. 718).
57. Sutcliffe SB, Chapman RM, Protection of ovarian function by oral contraceptives in women receiving chemotherapy for Hodgkin's disease. Blood 1981; 58: 849-851.
58. Chatterjee R, Mills W, Katz M et al. Induction of ovarian function by using short-term human menopausal gonadotrophin in patients with ovarian failure following cytotoxic chemotherapy for haematological malignancy. Leuk Lymphoma 1993; 10: 383-386.
59. De Moraes-Ruehsen M, Jones GS. A new method of amenorrhoea in association with hyperandrogenism and apparently normal folhcular apparatus. Am J Obstet Gvnecol 1969; 104: 597-600.
60. Rebar RW, Connolly HV. Clinical features of young women with hypergonadotrophic amenorrhoea. Fertil Steril 1990; 53: 804-810.
61. Human Fertilization and Embryology Act. London, Her Majesty's Stationery Office: London, 1990.
62. American Fertility Society. The Ethics Committee of AFS. Ethical statement on in vitro fertilization. In: Ethical Considerations of the New Reproductive Techniques. Fertil Steril 1986; 46 (suppl 1): 89S.
63. Pope Pius XII Discourses. Braintree: MA, 29 September 1949.
64. Buskard N, Ballen T, Hill RS et al. Normal fertility after total body irradiation and chemotherapy in conjunction with a bone marrow transplant for acute leukaemia. Clin Invest 1988; 11: 57-62.
65. Milliken S, Powles R, Parikh P et al. Successful pregnancy following bone marrow transplantation for leukaemia. Bone Marrow Transplant 1990; 5: 135-137.
66. Salooja N, Chatterjee R, McMillan AK et al. Successful pregnancy in women following single autotransplant for AML with a chemotherapy ablation protocol. Bone Marrow Transplant 1994; 13: 431-435.
67. Byrne J. Mulvhill JJ. Long-term survivors of childhood and adolescent cancer: their fertility and the health of the off-spring. In: Plowman PN. McElwain T, Meadows A (eds). Complications of Cancer Management. Butterworth-Heineman: New York, 1992, pp 114-127.
68. Byrne J, Mulvhill JJ, Myers NH et al. Effects of cancer treatment on fertility in long-term survivors of childhood or adolescent cancer. New Engl J Med 1987; 317: 1315-1318.
69. Weiss NS, Urec L, Ballard JH. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. New Engl J Med 1980; 303: 1195-1198.
70. Christiansen C, Christiansen MS, McNair P et al. Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females. Eur J Clin Invest 1980; 10: 273-279.
71. Nachtigall LE, Nachtigall RH, Nachtigall RD et al. Estrogen replacement II: a prospective study in the relationship to carcinoma and cardiovascular disease and metabolic problems. Obstet Gynecol 1979; 54: 74-79.
72. Steinberg KK, Thacker SB, Smith J et al. A meta analysis of the effect of estrogen replacement therapy on the risk of breast cancer. JAMA 1991; 265: 1985-1990.
73. Dupont WD, Page DL. Menopausal estrogen therapy and breast cancer. Arch Intern Med 1991; 151: 67-72.
74. Barrett-Connor E. Postmenopausal estrogen replacement and breast cancer. New Engl J Med 1989; 321: 319-320 (editorial).
75. Bergvisk I, Adami HO, Persson I et al. The risk of breast cancer after estrogen-progesterone. New Engl J Med 1989; 321: 293-297.
76. Gembrell RD. Proposal to decrease the risk and improve the prognosis of breast cancer. Am J Obstet Gynecol 1984; 150: 119-132.
77. Hsueh AJW, Peck EJ, Clark JH. Control of uterine estrogen receptor levels by progesterone. Endocrinology 1976; 98: 438-444.
78. Staland B. Continuous treatment with natural oestrogens and progestogens. A method to avoid endometrial stimulation. Maturitas 1981; 3: 145-156.
79. Abdalla HI, Hart DM, Lindsay R et al. Prevention of bone mineral loss in postmenopaosal women by norethisterone. Obstet Gynecol 1985; 66: 789-792.